Komori
Japan Lifeline (7575) · InitiativePlanned review of the board compositionLatest Governance (2026-06-26): "Advanced"

Board Oversight and Auditing by Independent Outside Officers

First written in FY2017. 6 of 9 entries say "Advanced", first in FY2018. Latest entry: 2026-06-26.

9entries
10years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018 – FY2022RestatedFY2023 – FY20252017: 120172018: 120182019: 120192020: 020202021: 120212022: 120222023: 120232024: 020242025: 120252026: 22026
Same theme, other companies
Oversight structure involving outside directors and independent officersA theme 511 companies write about · 0 as a headwind · 520 as a tailwind

The whole theme swung hardest in 2023: 14 of 103 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 520 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025Planned review of the board compositionAnnual report

    「The company has proposed, as matters for resolution at the Annual General Meeting of Shareholders scheduled for 26 June 2025, the election of 10 directors excluding directors who are Audit and Supervisory Committee members and the election of 3 directors who are Audit and Supervisory Committee members. If the proposals are approved, the company will have 13 directors, including 5 outside directors.」

    The company presented a proposal to change from the current structure of 16 directors, including 6 outside directors, to a structure of 13 directors, including 5 outside directors, after the Annual General Meeting of Shareholders.
  2. FY2023RestatedAnnual report

    「The company has established a structure for appropriate oversight of the execution of duties by appointing 6 outside directors, 3 of whom are Audit and Supervisory Committee members, to provide recommendations and advice to the board from objective and diverse perspectives.」

    The company continues to maintain an independent oversight and audit structure comprising 6 outside directors, including 3 Audit and Supervisory Committee members.
  3. FY2022AdvancedAnnual report

    「The company currently comprises 11 directors excluding directors who are Audit and Supervisory Committee members, and 4 directors who are Audit and Supervisory Committee members. Of the directors, 6 are outside directors, all of whom have been appointed as independent officers.」

    Following the change to a company with an Audit and Supervisory Committee, the company describes the operation of the board and the Audit and Supervisory Committee, specifying an oversight and audit structure comprising 6 outside directors and 4 Audit and Supervisory Committee members.
  4. FY2021AdvancedAnnual report

    「To strengthen the audit and oversight functions over the execution of duties, further enhance its corporate governance structure, and improve management transparency and objectivity, the company changed from a company with a board of corporate auditors to a company with an Audit and Supervisory Committee pursuant to a resolution at the 41st Annual General Meeting of Shareholders held on 25 June 2021. The board has established a structure for appropriate oversight of the execution of duties by appointing 6 outside directors, 3 of whom are Audit and Supervisory Committee members, thereby obtaining recommendations and advice from objective and diverse perspectives.」

    The company changed from a company with a board of corporate auditors to a company with an Audit and Supervisory Committee, and its oversight structure changed to include 6 outside directors.
  5. FY2019AdvancedAnnual report

    「In addition, the company has established a voluntary Nomination and Compensation Advisory Committee as an advisory body to the board. More than half of its members are independent outside directors, and an independent outside director serves as chair. The committee deliberates on the nomination and compensation of directors and corporate auditors, establishing a structure for appropriate management oversight.」

    The company established a 4-member Nomination and Compensation Advisory Committee, including 2 independent outside directors, adding an oversight function for the nomination and compensation process with an independent outside director as chair.
  6. FY2018AdvancedAnnual report

    「The company's board of directors comprises 12 directors, including 2 outside directors. It holds one regularly scheduled board meeting each month and extraordinary meetings whenever necessary, makes important management decisions and supervises the execution of directors' duties. The outside directors have been appointed as independent officers and provide oversight and advice to the board from an independent standpoint while coordinating with the other independent officers.」

    The board now comprises 12 directors, including 2 outside directors, and continues to provide oversight and advice through its independent officers.
  7. FY2017First statedAnnual report

    「The company's board of directors comprises 11 directors, including 2 outside directors. It holds one regularly scheduled board meeting each month and extraordinary meetings whenever necessary, makes important management decisions and supervises the execution of directors' duties.」

    The company specifically describes the oversight and advisory functions of its board, which includes 2 independent outside directors, and its audit structure, which includes outside corporate auditors.
Moved together

"Medical Device Business Covering Both Trading and Manufacturing" moved the same way as this thread, in the same document, in 4 of its 9 moves.

444222★123456
  1. ★This thread
  2. 1Medical Device Business Covering Both Trading and Manufacturing4×
  3. 2Expansion of Unique, High-Value-Added Proprietary Products4×
  4. 3Expansion of medical devices beyond the cardiovascular field and entry into the gastrointestinal field4×
  5. 4International Expansion of Japanese Medical Devices2×
  6. 5Absorbing Declines in Product Prices and Achieving Stable Growth2×
  7. 6Development of High-Value-Added Disposable Catheters2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Lifeline's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Governance of 2026-06-26: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Board Oversight and Auditing by Independent Outside Officers | Japan Lifeline Co.,Ltd. (7575) | Komori